Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Pratt

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Pharmacoepidemiology and Drug Safety|February 11, 2025
Utilisation Trends of Lisdexamfetamine: Insights From Recent Medicine Shortages in AustraliaJack Janetzki, Lisa Kalisch, Kelly Hall, et al.
Pharmacoepidemiology and Drug Safety|May 4, 2007
Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitionersElizabeth Roughead, Nicole Pratt, Robert Peck, et al.
Australian and New Zealand Journal of Public Health|December 8, 2010
Factors associated with choice of antipsychotic treatment in elderly veterans: potential confounders for observational studiesNicole Pratt, Elizabeth Roughead, Amy Salter, et al.
BMC Medical Research Methodology|June 12, 2012
Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic reviewNicole Pratt, Elizabeth E Roughead, Amy Salter, et al.
Pharmacoepidemiology and Drug Safety|June 29, 2010
Antipsychotics and the risk of death in the elderly: an instrumental variable analysis using two preference based instrumentsNicole Pratt, Elizabeth E Roughead, Philip Ryan, et al.
Applied Health Economics and Health Policy|October 27, 2018
Using Post-market Utilisation Analysis to Support Medicines Pricing Policy: An Australian Case Study of Aflibercept and Ranibizumab UseAnna Kemp-Casey, Nicole Pratt, Emmae Ramsay, et al.
Drug Safety|July 2, 2026
Implementation Aspects of a Medicines Shortage Policy Tool: Evidence from Australia's Serious Scarcity Substitution InstrumentsJack Janetzki, Lisa Kalisch-Ellett, Nicole Pratt, et al.
Artificial Intelligence in Medicine|June 6, 2020
Detecting potential signals of adverse drug events from prescription dataChen Zhan, Elizabeth Roughead, Lin Liu, et al.
Age and Ageing|October 28, 2015
Predictive performance of four frailty measures in an older Australian populationImaina S Widagdo, Nicole Pratt, Mary Russell, et al.
Journal of Biomedical Informatics|July 18, 2018
A data-driven method to detect adverse drug events from prescription dataChen Zhan, Elizabeth Roughead, Lin Liu, et al.
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Pharmacoepidemiology and Drug Safety|February 11, 2025
Utilisation Trends of Lisdexamfetamine: Insights From Recent Medicine Shortages in AustraliaJack Janetzki, Lisa Kalisch, Kelly Hall, et al.
Pharmacoepidemiology and Drug Safety|May 4, 2007
Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitionersElizabeth Roughead, Nicole Pratt, Robert Peck, et al.
Australian and New Zealand Journal of Public Health|December 8, 2010
Factors associated with choice of antipsychotic treatment in elderly veterans: potential confounders for observational studiesNicole Pratt, Elizabeth Roughead, Amy Salter, et al.
BMC Medical Research Methodology|June 12, 2012
Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic reviewNicole Pratt, Elizabeth E Roughead, Amy Salter, et al.
Pharmacoepidemiology and Drug Safety|June 29, 2010
Antipsychotics and the risk of death in the elderly: an instrumental variable analysis using two preference based instrumentsNicole Pratt, Elizabeth E Roughead, Philip Ryan, et al.
Applied Health Economics and Health Policy|October 27, 2018
Using Post-market Utilisation Analysis to Support Medicines Pricing Policy: An Australian Case Study of Aflibercept and Ranibizumab UseAnna Kemp-Casey, Nicole Pratt, Emmae Ramsay, et al.
Drug Safety|July 2, 2026
Implementation Aspects of a Medicines Shortage Policy Tool: Evidence from Australia's Serious Scarcity Substitution InstrumentsJack Janetzki, Lisa Kalisch-Ellett, Nicole Pratt, et al.
Artificial Intelligence in Medicine|June 6, 2020
Detecting potential signals of adverse drug events from prescription dataChen Zhan, Elizabeth Roughead, Lin Liu, et al.
Age and Ageing|October 28, 2015
Predictive performance of four frailty measures in an older Australian populationImaina S Widagdo, Nicole Pratt, Mary Russell, et al.
Journal of Biomedical Informatics|July 18, 2018
A data-driven method to detect adverse drug events from prescription dataChen Zhan, Elizabeth Roughead, Lin Liu, et al.
Pageof 13